FDA Creates New Advisory Committee for Evaluation of Genetic Metabolic Disease Treatments

Home
EVENTS CONFERENCES AND FUNDING OPPORTUNITIES
Research

DEC

2023

Today, the U.S. Food and Drug Administration announced it is creating a new advisory committee related to potential treatments for genetic metabolic diseases.

https://www.fda.gov/news-events/press-announcements/fda-creates-new-advisory-committee-evaluation-genetic-metabolic-disease-treatments

View all the news and events

Conference

Rare 2026

From June 17, 2026 to June 18, 2026

7th International Conference on Rare Diseases (RARE2026), which will take place 17-18 June 2026 in Kraków, Poland. …

FDA Creates New Advisory Committee for Evaluation of Genetic Metabolic Disease Treatments

Related articles

Rare 2026